Genital Chlamydia trachomatis Infections Clear More Slowly in Men Than Women, but Are Less Likely to Become Established
- PMID: 28838150
- PMCID: PMC5854005
- DOI: 10.1093/infdis/jix283
Genital Chlamydia trachomatis Infections Clear More Slowly in Men Than Women, but Are Less Likely to Become Established
Erratum in
-
Erratum.J Infect Dis. 2018 Jan 17;217(3):511. doi: 10.1093/infdis/jix505. J Infect Dis. 2018. PMID: 29351674 Free PMC article. No abstract available.
Abstract
Background: Rigorous estimates for clearance rates of untreated chlamydia infections are important for understanding chlamydia epidemiology and designing control interventions, but were previously only available for women.
Methods: We used data from published studies of chlamydia-infected men who were retested at a later date without having received treatment. Our analysis allowed new infections to take one of 1, 2, or 3 courses, each clearing at a different rate. We determined which of these 3 models had the most empirical support.
Results: The best-fitting model had 2 courses of infection in men, as was previously found for women: "slow-clearing" and "fast-clearing." Only 68% (57%-78%) (posterior median and 95% credible interval [CrI]) of incident infections in men were slow-clearing, vs 77% (69%-84%) in women. The slow clearance rate in men (based on 6 months' follow-up) was 0.35 (.05-1.15) year-1 (posterior median and 95% CrI), corresponding to mean infection duration 2.84 (.87-18.79) years. This compares to 1.35 (1.13-1.63) years in women.
Conclusions: Our estimated clearance rate is slower than previously assumed. Fewer infections become established in men than women but once established, they clear more slowly. This study provides an improved description of chlamydia's natural history to inform public health decision making. We describe how further data collection could reduce uncertainty in estimates.
Keywords: Bayesian inference; chlamydia; evidence synthesis; natural history; sexually transmitted diseases.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America.
Figures
References
-
- Chow JM, Bauer HM. What data are really needed to evaluate the population impact of chlamydia screening programs? Sex Transm Dis 2016; 43:9–11. - PubMed
-
- Gottlieb SL, Xu F, Brunham RC. Screening and treating Chlamydia trachomatis genital infection to prevent pelvic inflammatory disease: interpretation of findings from randomized controlled trials. Sex Transm Dis 2013; 40:97–102. - PubMed
-
- Public Health England. Opportunistic chlamydia screening of young adults in England: an evidence summary. London: Public Health England, 2014.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
